Trial
NCT03361800
Window of Opportunity Trial of Entinostat in Patients With Newly Diagnosed Stage I-IIIC,TNBC
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
UNC Lineberger Comprehensive Cancer Center
Collaborators
Syndax Pharmaceuticals; National Cancer Institute (NCI)
Condition
Breast Cancer
Intervention
Entinostat
Why stopped
Funding withdrawn.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-25